Yavuz Tunzala, Sarac Omurhan, Yeniay Hicret, Nadir Yasemin, Alpdogan Ozcan
Intensive Care Unit, Tepecik Training and Research Hospital, Health Sciences University, Izmir, TUR.
Anesthesiology and Critical Care, Izmir Bayraklı City Hospital, Izmir, TUR.
Cureus. 2024 Jun 13;16(6):e62297. doi: 10.7759/cureus.62297. eCollection 2024 Jun.
This study aimed to investigate the clinical characteristics and prognostic factors of critically ill COVID-19 patients with renal failure admitted to the ICU.
We analyzed 300 adult patients with SARS-CoV-2 infection admitted to the ICU between November 1, 2020, and June 1, 2022. Demographic data, renal function parameters, and outcomes were collected and analyzed.
The median age was 72 years, and 54.3% were men. Mechanical ventilation was required for 86.3% of patients, with 71.0% needing invasive ventilation. Renal failure was present in 43.3% of patients at ICU admission, significantly associated with older age, higher mechanical and invasive ventilation needs, and increased ICU mortality (76.9% vs. 51.8%, p<0.001). Patients with renal failure had elevated levels of urea, creatinine, C-reactive protein (CRP), D-dimer, white blood cell (WBC), neutrophil (Neu), and procalcitonin (PCT) (p<0.001 for all). Among patients with acute kidney injury (AKI), those with AKI had significantly higher median age (75 vs. 66 years, p<0.001), mechanical ventilation requirement (93.6% vs. 74.3%, p<0.001) and ICU mortality (79.1% vs. 35.4%, p<0.001). Elevated levels of urea (76 vs. 44 mg/dL, p<0.001) and creatinine (1.4 vs. 0.8 mg/dL, p<0.001), as well as inflammatory markers CRP and D-dimer (p=0.001), were observed in AKI patients. Survivors had lower median age (66.0 vs. 74.0 years, p<0.001) and lower prevalence of chronic kidney disease (CKD) (4.5% vs. 12.8, p=0.019) and AKI (34.8% vs. 78.7%, p<0.001). Non-survivors exhibited higher levels of urea, creatinine, lactate dehydrogenase (LDH), CRP, ferritin, and D-dimer (p<0.001 for all).
Renal failure and AKI are prevalent in critically ill COVID-19 patients and are associated with worse outcomes. Elevated creatinine and urea levels at ICU admission are significant predictors of ICU mortality, underscoring the importance of early recognition and management of renal impairment in these patients.
本研究旨在调查入住重症监护病房(ICU)的新冠肺炎合并肾衰竭重症患者的临床特征及预后因素。
我们分析了2020年11月1日至2022年6月1日期间入住ICU的300例成年新冠病毒感染患者。收集并分析了人口统计学数据、肾功能参数及预后情况。
患者中位年龄为72岁,男性占54.3%。86.3%的患者需要机械通气,其中71.0%需要有创通气。43.3%的患者在入住ICU时已出现肾衰竭,这与年龄较大、机械通气和有创通气需求较高以及ICU死亡率增加显著相关(76.9%对51.8%,p<0.001)。肾衰竭患者的尿素、肌酐、C反应蛋白(CRP)、D-二聚体、白细胞(WBC)、中性粒细胞(Neu)和降钙素原(PCT)水平均升高(所有p<0.001)。在急性肾损伤(AKI)患者中,AKI患者的中位年龄显著更高(75岁对66岁,p<0.001)、机械通气需求更高(93.6%对74.3%,p<0.001)以及ICU死亡率更高(79.1%对35.4%,p<0.001)。AKI患者的尿素(76对44mg/dL,p<0.001)和肌酐(1.4对0.8mg/dL,p<0.001)水平升高,以及炎症标志物CRP和D-二聚体升高(p=0.001)。存活患者的中位年龄较低(66.0对74.0岁,p<0.001),慢性肾脏病(CKD)患病率较低(4.5%对12.8,p=0.019),AKI患病率较低(34.8%对78.7%,p<0.001)。非存活患者的尿素、肌酐、乳酸脱氢酶(LDH)、CRP、铁蛋白和D-二聚体水平较高(所有p<0.001)。
肾衰竭和AKI在新冠肺炎重症患者中普遍存在,且与较差的预后相关。入住ICU时肌酐和尿素水平升高是ICU死亡率的重要预测指标,强调了早期识别和处理这些患者肾功能损害的重要性。